IE
PRNB

Israel Englander’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Israel Englander’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-75,244
Closed -$4.5M – 5030
2020
Q2 		$4.5M Sell
75,244
-5,240
-7% -$324K 0.01% 1873
2020
Q1 		$4.78M Buy
+80,484
New +$4.69M 0.01% 1361
2019
Q3 		– Sell
-38,716
Closed -$1.28M – 4732
2019
Q2 		$1.28M Buy
38,716
+19,250
+99% +$601K ﹤0.01% 2653
2019
Q1 		$662K Buy
19,466
+8,872
+84% +$282K ﹤0.01% 3103
2018
Q4 		$290K Sell
10,594
-131,331
-93% -$3.38M ﹤0.01% 3230
2018
Q3 		$4.15M Buy
+141,925
New +$4.01M 0.01% 1945

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Israel Englander's PRNB Position: Q3 2020 in Review

Israel Englander sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 75,244 shares — an estimated $4.5M sold.

Israel Englander first reported a position in PRNB in Q3 2018 and held it in 6 quarters. The position peaked at $4.78M in Q1 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Israel Englander reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Israel Englander sold 75,244 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $4.5M.
  • Israel Englander first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 6 quarters.
  • Israel Englander's Principia Biopharma Inc. Common Stock position peaked at $4.78M in Q1 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.